Zhengye Biotechnology Holding (ZYBT) Total Debt (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Total Debt for 3 consecutive years, with $10.4 million the latest figure, recorded in Q4 2025.

• Quarterly Total Debt fell 5.49% year-over-year to $10.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.4 million (down 5.49% YoY) and the FY2025 annual result came in at $10.4 million, down 3.97% from the prior year.
• Total Debt rose to $10.4 million in Q4 2025 per ZYBT's latest filing, from $677438.4 in the prior quarter.
• Over the last five years, Total Debt for ZYBT reached as high as $12.5 million in Q4 2023 and fell as low as $677438.4 in Q2 2025.
• A 3-year average of $8.7 million and a median of $10.7 million in 2024 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2024 — Total Debt decreased 11.6% — and 2025, when it slipped 5.49%.
• Year by year, Total Debt stood at $12.5 million in 2023, then retreated by 11.6% to $11.0 million in 2024, then fell by 5.49% to $10.4 million in 2025.
• According to Business Quant data, Total Debt over the past three periods registered $10.4 million, $677438.4, and $11.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.